NET PROFIT (x1000 NOK)
EMPLOYEES
Empros Pharma AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
-10,465
|
-8,681
|
-11,574 |
| EBITDA |
-11,839
|
-8,715
|
-11,575 |
| Total assets |
149,185
|
72,518
|
56,227 |
| Current assets |
34,024
|
7,459
|
5,609 |
| Current liabilities |
7,226
|
4,517
|
1,417 |
| Equity capital |
141,959
|
68,002
|
54,810 |
| - share capital |
182
|
147
|
137 |
| Employees (average) |
8
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
95.2%
|
93.8%
|
97.5% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-7.0%
|
-12.0%
|
-20.6% |
| Current ratio |
470.9%
|
165.1%
|
395.8% |
| Return on equity (ROE) |
-7.4%
|
-12.8%
|
-21.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
1
|
0
|
1 |
| Chg. No. of employees % |
14%
|
0%
|
17% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.